RELX grows proceeds 7% as AI-enabled instruments drive demand

RELX shares have rebounded about 50% from the lows hit in the course of the peak of AI disruption fears earlier this yr. Today’s buying and selling assertion goes a protracted method to validating that rally.

The firm reported robust proceeds development within the first 9 months of the yr and reaffirmed its full-year outlook, as demand for its AI-enabled analytics and information instruments rose.

– Advertisement –

RELX is an attention-grabbing case. It isn’t being negatively impacted by AI because the market has feared, nevertheless it’s not seeing explosive development from its adoption both.

The info and analytics group mentioned underlying proceeds rose 7% within the interval, pushed by a continued shift in the direction of higher-growth analytics and choice instruments throughout its companies. Its authorized division led the best way with 10% development as prospects adopted its AI-enabled authorized analysis platform, whereas its danger corporate affairs grew 8% on demand for fraud and financial-crime compliance instruments, and its scientific and medical arm grew 6%.

Its exhibitions corporate affairs grew 4%, although disruption within the Middle East held it again. RELX mentioned it continued to embed synthetic intelligence throughout its merchandise, citing robust early reception for a brand new analysis instrument and increasing “agentic” capabilities in its authorized platform.

The firm mentioned it anticipated one other yr of robust development in proceeds, revenue, and earnings, with revenue rising quicker than proceeds throughout most divisions.

RELX shares had been down 0.3% on the time of writing on Thursday.